Cno Financial Group, INC
Market Movers (8-K)
NYSE
CNO Financial Group announced robust second quarter 2026 financial results, driven by strong sales momentum and improved profitability, leading to an 8% increase in full-year operating EPS guidance.
Better than expected
NYSE
CNO Financial Group shareholders re-elected all nine director nominees and ratified executive compensation and auditors.
NYSE
CNO Financial Group reported strong first quarter 2026 results, highlighted by a 33% increase in operating earnings per share and sustained sales momentum.
NYSE
CNO Financial Group announced a quarterly dividend of $0.17 per share and the retirement of Director Nina Henderson.
NYSE
CNO Financial Group achieved record sales and strong earnings growth in 2025, exceeding all guidance metrics and returning $386 million to shareholders.
Better than expected
Capital raise
NYSE
CNO Financial Group announced the appointment of Linda Gibson, a seasoned investment management executive, as an independent director to its Board, increasing its size to ten members.
Quarterly Earnings (10-Q)
NYSE
CNO Financial Group reported increased net operating income for Q3 2025, alongside a significant goodwill impairment and a strategic decision to exit its fee services business to sharpen focus on core insurance operations.
Worse than expected
NYSE
CNO Financial Group reports a decline in second-quarter net income and diluted earnings per share, primarily due to market-driven fair value adjustments, while reaffirming its full-year operating outlook.
Worse than expected
NYSE
CNO Financial Group's Q1 2025 results show a mix of increased operating income offset by net non-operating losses, while the company reaffirms its full-year guidance.
Worse than expected
NYSE
10-Q: CNO Financial Group Reports Mixed Results in Q3 2024 Amidst Actuarial Review and Market Volatility
CNO Financial Group's Q3 2024 results show a complex picture with a net income of $9.3 million, impacted by an actuarial review and market fluctuations.
Worse than expected
NYSE
CNO Financial Group's second quarter results show a significant increase in net operating income and a raised full-year outlook, driven by strong investment performance and disciplined expense management.
Better than expected
NYSE
CNO Financial Group's first quarter 2024 results show a net income of $112.3 million, a significant improvement compared to a net loss in the same period last year.
Better than expected
Annual Reports (10-K)
NYSE
CNO Financial Group's 2025 net income declined significantly due to one-time charges, though operating income saw a modest increase, driven by strong premium collections and strategic business exits.
NYSE
CNO Financial Group's annual report reveals a net income of $404 million for 2024, driven by its insurance and investment operations.
NYSE
CNO Financial Group, Inc. has released its 10-K report for the fiscal year ending December 31, 2023, revealing a complex interplay of market dynamics, regulatory changes, and strategic financial management.
Insider Trading (Form 4)
NYSE
Gary C. Bhojwani, CEO of CNO Financial Group, Inc., reported the sale of 44,250 shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Rocco F. Tarasi III, Chief Marketing Officer of CNO Financial Group, Inc., sold 1,891 shares of common stock for $51.31 per share as part of a pre-arranged trading plan.
NYSE
Rocco F. Tarasi III, Chief Marketing Officer at CNO Financial Group, Inc., reported transactions involving the sale and acquisition of company stock and stock options.
NYSE
Scott L. Goldberg, President of Consumer Division at CNO Financial Group, Inc., reported a transaction involving the surrender of shares to cover tax withholding obligations.
NYSE
Rocco F. Tarasi III, Chief Marketing Officer of CNO Financial Group, Inc., sold 4,808 shares of common stock on June 2, 2026, as part of a pre-arranged trading plan.
NYSE
CNO Financial Group Director Archie Brown acquired 3,574 shares of common stock at $46.17 per share through a restricted stock unit award.
Proxy Statements (Def-14A)
NYSE
CNO Financial Group reports strong 2025 financial and operational performance, highlighted by record sales and profitability, while outlining proposals for its 2026 Annual Meeting of Shareholders.
Worse than expected
NYSE
CNO Financial Group, Inc. has filed a definitive proxy statement with the SEC.
NYSE
CNO Financial Group's proxy statement outlines key proposals for the upcoming shareholder meeting, including director elections, executive compensation, and amendments to incentive plans.
Better than expected
NYSE
CNO Financial Group has filed its definitive proxy statement with the SEC, outlining matters for shareholder consideration.
NYSE
CNO Financial Group's proxy statement outlines proposals for the upcoming annual shareholder meeting, including director elections, executive compensation, and shareholder rights plan.
Institutional Holdings (13F)
NYSE
CNO Financial Group, Inc. filed its quarterly Form 13F, detailing its investment holdings as of March 31, 2026, with a total portfolio value of $174,426,642.
NYSE
CNO Financial Group, Inc. reveals $176.5M in Q4 2025 equity holdings, primarily ETFs, across 19 positions.
NYSE
CNO Financial Group discloses its institutional equity holdings for the quarter ended September 30, 2025, totaling over $150 million.
NYSE
CNO Financial Group, Inc. filed its Q2 2025 Form 13F-HR, detailing $161.76 million in managed securities holdings as of June 30, 2025.
NYSE
CNO Financial Group's latest 13F filing discloses $119.6 million in managed assets as of March 31, 2025, with significant holdings in various ETFs and corporate stocks.
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management reports beneficial ownership of 4,825,453 shares, representing 5.14% of CNO Financial Group Inc.'s common stock.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 7.23% in CNO Financial Group Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in CNO Financial Group Inc. following an internal realignment.
NYSE
BlackRock, Inc. has filed an Amendment No. 14 to its Schedule 13G, disclosing a beneficial ownership of 12.9% of CNO Financial Group, Inc.'s common stock.